Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport.
about
VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuseExpression cloning of a reserpine-sensitive vesicular monoamine transporterHow addictive drugs disrupt presynaptic dopamine neurotransmissionVesicular monoamine transporter 2: role as a novel target for drug developmentPreferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cellsExpression and purification of recombinant vesicular glutamate transporter VGLUT1 using PC12 cells and High Five insect cellsMechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicityOsmotic surveillance mediates rapid wound closure through nucleotide release.A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant YellowDesign, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.Vmat2 heterozygous mutant mice display a depressive-like phenotype.31P nuclear magnetic resonance study of the metabolic pools of adenosine triphosphate in cultured bovine adrenal medullary chromaffin cells.The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Neurosecretory vesicles can be hybrids of synaptic vesicles and secretory granulesSecretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathwayImpairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity.Striatal dopamine neurotransmission: regulation of release and uptakeIdentification of a vesicular nucleotide transporter.CNS dopamine transmission mediated by noradrenergic innervation.Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells.Pheochromocytoma and paraganglioma.Glucose triggers ATP secretion from bacteria in a growth-phase-dependent mannerHIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomesCoexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioraVesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling.Divalent cation transport by vesicular nucleotide transporter.Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein.Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.pH-dependent processing of secretogranin II by the endopeptidase PC2 in isolated immature secretory granules.Bacteriorhodopsin drives the glutamate transporter of synaptic vesicles after co-reconstitution.High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.ATP-dependent bile-salt transport in canalicular rat liver plasma-membrane vesicles.The heterotrimeric G protein Go2 regulates catecholamine uptake by secretory vesicles.Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys.Secretory vesicle rebound hyperacidification and increased quantal size resulting from prolonged methamphetamine exposure.The role of myosin in vesicle transport during bovine chromaffin cell secretion.Stimulation-dependent regulation of the pH, volume and quantal size of bovine and rodent secretory vesicles.
P2860
Q22242306-C9C87E2A-8F26-4798-A438-DB2529E37418Q24563187-BBD857AB-EF42-452C-94A2-D53666AE361EQ24631269-D147A608-709F-4FDC-97C3-5AB6D16AAA93Q24647764-120629DA-40AC-4E51-8016-432ED482CC4AQ24673073-FBFEFE5E-105F-4DDD-A744-54983A10357BQ24807160-E544096A-B926-4610-A140-46B2E0952839Q27333086-78F854E9-552C-49F9-AC21-A2B869FF638FQ28512294-095C49A6-4ACF-42C3-A852-01321F114685Q30610768-37928EC2-8518-4FD1-9C63-FC1969DB8EB7Q33630896-60DD4705-6D8E-4513-BB53-BC3EDE66C940Q33738102-F6F06EF3-7B82-4B0F-8109-FB698CB3DC23Q33793549-785C54D6-434F-4994-9A46-3854DCCD179CQ33846677-73B4988F-2950-4ABD-8B14-13ABB7627C6EQ33854736-EE9F446C-47CE-41DE-B727-DDC58CF7EDD1Q34047927-E62840BD-BD57-4820-9AD1-6533482846C1Q34172415-07494373-83BE-4025-9055-7AAA69794541Q34375659-F840FDCA-2BA3-4775-8375-18FEC6E71D64Q34524803-BF182A15-387E-43F1-B257-02575A85DAC8Q34765722-5489AACC-9EC5-4787-818D-9AA325A1D425Q36020737-2AD3258E-8771-45F7-8C84-71EB97385F19Q36274338-B927F106-BEB3-410D-BC36-17D01FE066B8Q36467162-58AEC6D3-25C4-4781-9021-1E53B2C5A507Q36757348-F4673C2E-7B42-4785-A38F-6CBB3978B25BQ36944251-B57A0E10-FEAE-4D9A-82D3-DD83E25CE830Q36969314-79409AAC-8BD3-43A4-8A37-38E737487209Q39375097-08840965-2D2E-4728-9D62-0AAF64BD7645Q39708253-44E84747-59B6-42D1-9019-9D612B16E98DQ39728880-4B4F7E27-7A12-412A-8FEF-B3B612185D90Q39868006-48E8C257-7BD6-4A1C-80BD-E5B958D40E18Q40820717-CD8529A8-72FE-415F-AD4E-831A5B63D099Q41138497-7FAA9E0D-5D87-4AFB-9C34-F3F21CCD1908Q41142545-A6ABF7E8-BCBD-48E0-B134-FC02147917AEQ41209176-23034E24-60BD-4D6B-AC06-D1D8CB22FD48Q41961292-7FD3FD48-1359-4B17-A087-6FFD3FC7EAD7Q41978000-20C2B735-C192-42EB-BEC4-A3B9490CF2E9Q42043500-0A708627-457E-4B6A-A7F0-713BE64BDBECQ42512645-E8A95F43-6CEF-4364-AD51-27A262FC9CB4Q42721475-AFEB5F38-1DCF-4C32-9E79-EE8429FF41FDQ43002455-CAE60160-8F3A-4FC7-9D61-8DB6C6FDC318Q44067079-A6FCA01A-2CCA-49C5-A82E-BEDC740536D1
P2860
Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Accumulation of biological ami ...... nd neurotransmitter transport.
@en
Accumulation of biological ami ...... nd neurotransmitter transport.
@nl
type
label
Accumulation of biological ami ...... nd neurotransmitter transport.
@en
Accumulation of biological ami ...... nd neurotransmitter transport.
@nl
prefLabel
Accumulation of biological ami ...... nd neurotransmitter transport.
@en
Accumulation of biological ami ...... nd neurotransmitter transport.
@nl
P1476
Accumulation of biological ami ...... nd neurotransmitter transport.
@en
P2093
Johnson RG Jr
P304
P356
10.1152/PHYSREV.1988.68.1.232
P577
1988-01-01T00:00:00Z